HL Financial Services’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-26,000	Closed	-$88K	–	800
2018 Q3	$88K	Hold	26,000	–	–	﹤0.01%	739
2018 Q2	$98K	Buy	26,000 +3,000	+13%	+$11.3K	﹤0.01%	671
2018 Q1	$94K	Buy	23,000 +8,000	+53%	+$32.7K	﹤0.01%	681
2017 Q4	$70K	Buy	+15,000	New	+$70K	﹤0.01%	602